Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Janssen-cilag Ltd.

Clinical trials sponsored by Janssen-cilag Ltd., explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

A pharmaceutical company, subsidiary of Johnson & Johnson.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet finished but already full! 2 Completed 4 Terminated 1

Psoriasis patients switch biologics in new Real-World study

Disease control Terminated

This study watches 200 adults with moderate to severe psoriasis who switch from ustekinumab to guselkumab in everyday medical practice. Researchers track how well the new drug clears skin symptoms and check for side effects over 52 weeks. The goal is to see if guselkumab works sa…

Sponsor: Janssen-Cilag Ltd. • Aim: Disease control

Last updated Jul 29, 2026 00:00 UTC